Company News

Traditional methods of culture and susceptibility testing rely on biochemical and phenotypic analyses, which can take days to identify the causative pathogen(s). However, significant advances in clinical microbiology practice have been made in the past two decades stemming from the development of novel molecular diagnostic platforms. 

Syndromic testing has emerged as a transformative approach for diagnosing infectious diseases, enabling the simultaneous detection of multiple pathogens—including viruses, bacteria, fungi, and parasites—from a single patient sample. This innovative method is particularly beneficial in clinical situations where overlapping symptoms may indicate various infectious agents, allowing for rapid and accurate diagnoses. 

Key Differences from Traditional Diagnostic Methods 

Syndromic testing presents several advantages over traditional diagnostic methods: 

1. Multiplexing Capability: Unlike conventional tests that isolate and identify one pathogen at a time, syndromic testing enables the simultaneous detection of multiple pathogens, significantly streamlining the diagnostic process. 
2. Speed of Results: Syndromic tests typically offer quick turnaround times, allowing healthcare providers to make timely decisions regarding patient treatment. Traditional methods often involve longer waiting periods, which can delay patient care. 
3. Targeted Diagnostic Approach: By focusing on specific clinical syndromes—such as respiratory, meningitis, or gastrointestinal infections—syndromic testing provides a more tailored diagnostic strategy based on the patient's presenting symptoms. 
4. Comprehensive Detection: This testing modality excels in cases of polymicrobial infections by identifying a wider range of pathogens, while traditional methods usually focus on a single pathogen. This limitation can hinder their effectiveness in detecting co-infections. 
5. Use of Advanced Laboratory Techniques: Syndromic testing employs molecular techniques, such as polymerase chain reaction (PCR), in specialized laboratories. In contrast, traditional tests often rely on culture methods or serological tests combined with single PCR pathogen detection, which can be time-consuming and less sensitive. 

Advantages of Syndromic Testing 

The implementation of syndromic testing offers numerous benefits in clinical diagnostics: 

1. Rapid Results: Syndromic tests deliver quicker results, facilitating prompt diagnosis and treatment. 
2. Comprehensive Detection: Identifying multiple pathogens at once minimizes the need for individual tests, enhancing diagnostic efficiency. 
3. Improved Patient Management: A broader understanding of the involved infectious agents allows healthcare providers to customize treatment strategies, leading to better patient outcomes. 
4. Reduction of Unnecessary Antibiotic Use: By accurately pinpointing the exact pathogen, syndromic testing combats antibiotic resistance through more appropriate prescribing practices. 
5. Enhanced Infection Control: Rapid identification of infectious agents aids in implementing effective isolation and control measures in healthcare settings, thereby preventing potential outbreaks. 
6. Cost-Effectiveness: Despite the initial investment in technology, the long-term reduction in time and necessary tests results in overall cost savings. 
7. Versatility Across Sample Types: Syndromic tests can be performed on various sample types, including blood, urine, respiratory secretions, and stool, making them suitable for diverse clinical scenarios. 
8. Pathogen Differentiation by CT Values: This unique method enables the diagnosis of the key pathogen responsible for the disease based on cycle threshold (CT) values. 

Types of Infections Detected 

Syndromic testing can diagnose a variety of infections spanning multiple clinical syndromes, including: 

• Respiratory Infections: Such as influenza (types A and B), respiratory syncytial virus (RSV), coronaviruses (including SARS-CoV-2), and Streptococcus pneumoniae. 
• Gastrointestinal Infections: Including norovirus, rotavirus, Salmonella, Shigella, and Campylobacter. 
• CNS Infections: Various types of meningitis (bacterial and viral) and encephalitis, particularly viral forms such as herpes simplex virus. 

The Way Forward: Enhancing Clinical Diagnostics in Pakistan 

The adoption of syndromic testing has the potential to enhance the efficiency and effectiveness of diagnosing infectious diseases, ultimately supporting improved patient outcomes through timely and accurate diagnoses. Systems like the QIAstat-Dx play a critical role in advancing clinical care, particularly in regions like Pakistan, where there is a pressing need for rapid and comprehensive diagnostic tools to address public health challenges. 

Despite its limited availability in Pakistan, since the launch of QIAstat by Briogene Pakistan in 2019, there is a growing recognition among healthcare consultants for the demand for rapid PCR technologies. Although the cost of these tests remains high compared to traditional methods, their importance in delivering timely diagnoses cannot be overstated. The continued integration and implementation of syndromic testing will serve as a crucial step forward in the ongoing battle against infectious diseases. 

In Pakistan, Private Hospitals are enhancing their capabilities for syndromic testing for affording  class, but there is a dire need to introduce this to public sector for masses.   

Sources

• Syndromic Surveillance: [CDC Syndromic Surveillance] (https://www.cdc.gov/nssp/syndromic-surveillance.html) 
• Infectious Diseases: [CDC Infectious Diseases] (https://www.cdc.gov/infectiousdiseases/index.html) 
• Rapid Testing and Diagnostics: [WHO Diagnostics] (https://www.who.int/health-topics/diagnostics#tab=tab_1) 
• Understanding Syndromic Testing: [ASM on Syndromic Testing] (https://journals.asm.org/doi/full/10.1128/JCM.00545-16 ) 
• Guidelines on Testing: [CLSI](https://clsi.org/) 
• Research Articles: [NIH Library] (https://pubmed.ncbi.nlm.nih.gov/) 
• Research Publications on Syndromic Testing: [PubMed Central] (https://www.ncbi.nlm.nih.gov/pmc/)